Inhaled Corticosteroids for Asthma Treatment

Types, How They Work, and Efficacy

Inhaled corticosteroids (ICS), also known as inhaled steroids, are the most potent anti-inflammatory controller medications available today for asthma control and are used to decrease the frequency and severity of asthma symptoms. They are the current mainstay of treatment once a person with asthma needs a higher level of care than a rescue inhaler (bronchodilator).

Inhaled corticosteroids help prevent chronic asthma symptoms such as:

You and your physician may want to consider inhaled corticosteroids if any of the following apply:

  • You use rescue β-agonist treatments, such as albuterol, more than two days per week.
  • You have asthma symptoms more than twice weekly.
  • You meet certain criteria on spirometry.
  • Your asthma interferes with your daily activities.
  • You have needed oral steroids two or more times in the last year.
Young boy using asthma inhaler in a field
Seb Oliver / Getty Images

Types

Commonly inhaled corticosteroids or combination drugs that contain a steroid include the following. Which may be best for you depends on several factors, including the severity of your asthma and your overall health.

  • Advair HFA (fluticasone*/salmeterol)
  • Airsupra (albuterol/budesonide*)
  • Alvesco (ciclesonide)
  • Arnuity Ellipta (fluticasone furoate)
  • Asmanex HFA (mometasone)
  • Dulera (mometasone*/formoterol)
  •  Flovent HFA (fluticasone)
  • Pulmicort Flexhaler (budesonide)
  • Qvar RediHaler (beclomethasone)
  • Symbicort, Breyna (budesonide*/formoterol)

*Indicates corticosteroid component

These medications can be delivered via three different devices:

  • Metered dose inhalers (MDIs): These consist of a pressurized canister containing medication that fits into a plastic mouthpiece; a propellant spray helps deliver the medication into the lungs. Chlorofluorocarbons (CFCs) were used as a propellant until 2008 when the FDA banned them due to environmental concerns. They were replaced by hydrofluoroalkanes (HFAs), which remain in use today.
  • Dry powder inhalers (DPIs): With these, no propellant is involved. Instead, the medication is in the form of a dry powder, which you release by breathing in a deep, fast breath.
  • Nebulizer: Nebulizers turn liquid medicine into a mist. They come in electric or battery-run versions with either a mouthpiece or a mask.

How They Work

Inhaled corticosteroids prevent asthma symptoms by reducing inflammation in the bronchial tubes, or airways, that carry oxygen to the lungs. In addition, they reduce the amount of mucus produced by the bronchial tubes. This is achieved by blocking the late-phase immune reaction to an allergen, decreasing airway hyperresponsiveness and inflammation, and inhibiting inflammatory cells such as mast cells, eosinophils, and basophils. 

Inhaled steroids are a key part of asthma control for many. Some assume these drugs are the same as anabolic steroids used by some athletes and that they carry the same significant risks. Rest assured that these drugs are different.

Efficacy

Generally, inhaled corticosteroids are used for long-term treatment of asthma in people of all ages who require daily management. They are effective in preventing asthma attacks but require daily use in regularly spaced doses in order to be effective.

While not all people respond similarly to inhaled corticosteroids, they have been found to improve a number of important asthma outcomes such as:

Note that short-acting beta-2 agonists (SABAs) like albuterol are not steroids. They are bronchodilators that open up your airways by quickly relaxing your airway muscles, making breathing easier.

Side Effects

Since inhaled corticosteroids act locally in the airway, minuscule amounts of the medicine make its way into the rest of the body. Therefore, the risk of potentially serious side effects commonly experienced by people taking systemic steroid medications is significantly lower.

Overall, the risks associated with inhaled corticosteroids are very low, but there are several things you can do to mitigate them.

Local Side Effects 

Thrush (oral candidiasis) is one of the most common side effects of ICS, affecting up to a third of people using them. It almost always seems to occur as a result of ICS being delivered to the side of the mouth and throat, making proper administration technique very important.

Lowering the dosage, using a spacer (a chamber inserted between the inhaler and your mouth), and appropriately rinsing your mouth following inhalation all help lower your risk of thrush. Thrush can also be treated with topical or oral antifungals, such as nystatin. 

Other local side effects can include:

  • Dysphonia: Inhaled steroids can affect your voice, a phenomenon known as dysphonia, which impacts 5% to 58% of people taking the medication. It may be prevented by using a spacer and treated by decreasing the ICS dose temporarily and giving your vocal cords a rest.
  • Reflex cough and bronchospasm: These side effects can be prevented by using a spacer and inhaling in more slowly. If needed, pretreatment with a rescue inhaler can prevent these symptoms.

Systemic Side Effects

While uncommon, a number of systemic (body-wide) effects can occur with inhaled corticosteroids. Generally, there is a higher risk with higher doses. Potential side effects include:

  • Poor growth: While poor growth in children can result from inhaled corticosteroid use, poorly controlled asthma can also be a cause. In general, low and medium doses of ICS are potentially associated with small, non-progressive but reversible declines in growth of children. As a result, you and your child's asthma care provider should not only carefully monitor growth, but try to use the lowest possible medication dose that gets good control of your child's condition. You must weigh the potential benefits of good asthma control with the small but real possible side effect of slowed growth.
  • Osteoporosis: Low doses of ICS do not appear to affect bone density, but there are more effects as doses are increased. If you have risk factors for osteoporosis or already have a low bone density, you may want to consider taking calcium and vitamin D supplements or a bone-protecting treatment such as a bisphosphonate (available by prescription; brand names include Boniva and Fosamax).
  • Easy bruising: Bruising and thinning of the skin can occur in people using inhaled corticosteroids. The effect is dose-dependent, so decreasing the dose may be helpful.
  • Cataracts and glaucoma: Low and medium doses of ICS have not been associated with cataracts in kids, but a cumulative, lifetime effect associated with increased risk of cataracts has been noted in adults. Only people with a family history of glaucoma appear to have an increased risk of glaucoma with ICS use. As a result, people on these drugs should have periodic eye exams, especially if they are taking high doses or have a family history of elevated eye pressure.

A Word From Verywell

While inhaled corticosteroids improve asthma control more effectively than any other agent used as a single treatment, it is important to note that these drugs cannot relieve an asthma attack already in progress. A rescue inhaler is still needed for those situations.

9 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Barnes PJ. Inhaled corticosteroids. Pharmaceuticals (Basel). 2010;3(3):514-540. doi:10.3390/ph3030514

  2. National Jewish Health. FAQs on Inhaled Steroids for Asthma.

  3. American Academy of Allergy Asthma & Immunology. AAAAI Allergy & Asthma Medication Guide.

  4. U.S. Food & Drug Administration. Transition From CFC Propelled Albuterol Inhalers to HFA Propelled Albuterol Inhalers: Questions and Answers.

  5. MedlinePlus. Asthma - quick-relief drugs.

  6. Galván CA, Guarderas JC. Practical considerations for dysphonia caused by inhaled corticosteroids. Mayo Clin Proc. 2012;87(9):901-4. doi:10.1016/j.mayocp.2012.06.022

  7. Pandya D, Puttanna A, Balagopal V. Systemic effects of inhaled corticosteroids: an overview. Open Respir Med J. 2014;8:59-65. doi:10.2174/1874306401408010059

  8. National Osteoporosis Foundation. The How’s and Why’s of Osteoporosis Medications.

  9. Shroff S, Thomas RK, D'souza G, Nithyanandan S. The effect of inhaled steroids on the intraocular pressure. Digit J Ophthalmol. 2018;24(3):6-9. doi:10.5693/djo.01.2018.04.001

Additional Reading

By Pat Bass, MD
Dr. Bass is a board-certified internist, pediatrician, and a Fellow of the American Academy of Pediatrics and the American College of Physicians.